Therefore, excessive choroidal thinning and decreased vascularity after anti-VEGF therapy may be an undesired effect leading to deterioration in the choriocapillaris-RPE complex and development of geographic atrophy [37, 38]. This evidence concerns the gene VEGFA and atrophic macular degeneration.